Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Lymphoma, B-Cell × liposomal doxorubicin × Clear all

Phase

Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 23 Fallopian Tube Neoplasms 12 Breast Neoplasms 11 Neoplasms 10 Triple Negative Breast Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Solid Tumors 4 Neoplasm Metastasis 4 Sarcoma, Ewing 3 Sarcoma 3 Lymphoma 3 Carcinoma 3 Sarcoma, Kaposi 2 Rhabdomyosarcoma 2 Osteosarcoma 2 Multiple Myeloma 2 Lymphoma, T-Cell 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 AIDS-related Kaposi sarcoma 2 Urinary Bladder Neoplasms 1 Unrecognized Condition 1 Subcutaneous panniculitis-like T-cell lymphoma 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1

Interventions

Cyclophosphamide 36 fludarabine 28 Rituximab 25 obinutuzumab 10 fludarabine phosphate 9 Bendamustine Hydrochloride 9 pembrolizumab 7 Vincristine 6 Specimen Handling 6 Prednisone 6 Magnetic Resonance Spectroscopy 6 Leukapheresis 6 Lenalidomide 6 Etoposide 6 venetoclax 5 ibrutinib 5 Inotuzumab Ozogamicin 5 Doxorubicin 5 Biopsy 5 ublituximab 4 tazemetostat 4 glofitamab 4 Interleukin-2 4 polatuzumab vedotin 3 Radiation 3 Nivolumab 3 Ipilimumab 3 Immunotherapy, Adoptive 3 Gemcitabine 3 Dexamethasone 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05270057 2025-10-09

LONCA

Medical College of Wisconsin

Phase 1 Active not recruiting

Burkitt Lymphoma, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡